ArticleFrontiers in oncology2025
Case Report: A rare case of hepatic undifferentiated pleomorphic sarcoma: diagnostic dilemmas and multidisciplinary management strategies.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combination Therapy With Sintilimab and Anlotinib for Advanced Undifferentiated Pleomorphic Sarcoma: A Case Report and Literature Review.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Undifferentiated pleomorphic sarcoma of the liver is an extremely rare mesenchymal malignancy, and there is limited literature on its clinical manifestations, diagnostic challenges, and therapeutic strategies. The case is unique due to its large tumor size, encapsulated feature, and lack of vascular invasion, offering new insights into tumor characteristics. This case was documented to contribute to the understanding of this aggressive tumor and highlight the role of multidisciplinary management in achieving favorable outcomes. A 57-year-old female patient presented with persistent upper abdominal pain for over 2 months. Laboratory tests showed anemia, hypoalbuminemia, and elevated AFP, and imaging revealed a large hepatic mass with necrosis. Initially, imaging misdiagnosed the large hepatic mass as hepatocellular carcinoma, but subsequent pathology and immunohistochemistry confirmed it was undifferentiated pleomorphic sarcoma. The patient successfully underwent left hepatic lobectomy with clear margins, and the resected tumor was a high-grade spindle cell tumor with significant necrosis. Postoperatively, the patient recovered well and was discharged in stable condition, with recommendations for further molecular diagnostics and oncological follow-up. In conclusion, early surgical intervention and multidisciplinary approaches are crucial for managing rare and aggressive hepatic tumors, such as undifferentiated pleomorphic sarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.